- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
New Oral Drugs for Migraine ; volume:36 ; number:9 ; day:29 ; month:8 ; year:2022 ; pages:933-949 ; date:9.2022
CNS drugs ; 36, Heft 9 (29.8.2022), 933-949, 9.2022
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-022-00948-8
- URN
-
urn:nbn:de:101:1-2022120221322775047270
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Karsan, Nazia
- Goadsby, Peter J.
- SpringerLink (Online service)
Other Objects (12)
New drugs for migraine
Migraine drugs
Therapeutic novelties in migraine: new drugs, new hope?
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
The history and rationale of the development of new drugs for migraine treatment
Optimising migraine treatment: from drug-drug interactions to personalized medicine
Proteome-wide Mendelian randomization identified potential drug targets for migraine
New directions in migraine
Novel drug-loaded paper tablets for improved oral drug delivery
Are the current IHS guidelines for migraine drug trials being followed?
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Drug–Drug Interactions with Direct Oral Anticoagulants
New drugs for migraine
Migraine drugs
Therapeutic novelties in migraine: new drugs, new hope?
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
The history and rationale of the development of new drugs for migraine treatment
Optimising migraine treatment: from drug-drug interactions to personalized medicine
Proteome-wide Mendelian randomization identified potential drug targets for migraine
New directions in migraine
Novel drug-loaded paper tablets for improved oral drug delivery
Are the current IHS guidelines for migraine drug trials being followed?
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
Drug–Drug Interactions with Direct Oral Anticoagulants
New drugs for migraine
Migraine drugs
Therapeutic novelties in migraine: new drugs, new hope?
Correction to: Therapeutic novelties in migraine: new drugs, new hope?
The history and rationale of the development of new drugs for migraine treatment
Optimising migraine treatment: from drug-drug interactions to personalized medicine
Proteome-wide Mendelian randomization identified potential drug targets for migraine
New directions in migraine
Novel drug-loaded paper tablets for improved oral drug delivery
Are the current IHS guidelines for migraine drug trials being followed?
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate